e-Therapeutics (LSE:ETX) Dividend Payout Ratio : 0.00 (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Dividend Payout Ratio?

e-Therapeutics's dividend payout ratio for the months ended in Jul. 2023 was 0.00.

The historical rank and industry rank for e-Therapeutics's Dividend Payout Ratio or its related term are showing as below:

LSE:ETX's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-20), the Dividend Yield % of e-Therapeutics is 0.00%.

e-Therapeutics's Dividends per Share for the months ended in Jul. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

e-Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for e-Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Dividend Payout Ratio Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Dividend Payout Ratio

Get a 7-Day Free Trial

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of e-Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, e-Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

e-Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, e-Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where e-Therapeutics's Dividend Payout Ratio falls into.

e-Therapeutics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

e-Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jan. 2023 )	/	EPS without NRI (A: Jan. 2023 )
	=	0	/	-0.015
	=	N/A

e-Therapeutics's Dividend Payout Ratio for the quarter that ended in Jul. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jul. 2023 )	/	EPS without NRI (Q: Jul. 2023 )
	=	0	/	-0.01
	=	N/A

e-Therapeutics (LSE:ETX) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

e-Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021